deltatrials
Completed NA NCT03125083

Role of Inflammation in Psychiatric Disorders in Patients With Cutaneous Lupus

Sponsor: Société Française de Cardiologie

Conditions Psychiatric Disorders Skin Restricted Lupus
Interventions Biological dosage from plasma
Updated 8 times since 2017 Last updated: Jan 5, 2023 Started: May 5, 2017 Primary completion: Oct 24, 2018 Completion: Oct 24, 2018

A NA clinical study on Psychiatric Disorders and Skin Restricted Lupus, this trial is completed. The trial is conducted by Société Française de Cardiologie and has accumulated 8 data snapshots since 2017. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Feb 2023 — Jul 2024 [monthly]

    Completed NA

    Status: Unknown Status → Completed

  4. Jan 2021 — Feb 2023 [monthly]

    Unknown Status NA

  5. Jun 2019 — Jan 2021 [monthly]

    Unknown Status NA

    Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

  1. Jun 2018 — Jun 2019 [monthly]

    Recruiting NA

  2. Aug 2017 — Jun 2018 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  3. Jun 2017 — Aug 2017 [monthly]

    Not Yet Recruiting NA

    First recorded

May 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Société Française de Cardiologie
  • University Hospital, Clermont-Ferrand
Data source: University Hospital, Clermont-Ferrand

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Clermont-Ferrand, France